| 1. | ykha5244 | |
| 2. | fishingregg | |
| 3. | firefoxco | |
| 4. | compressor49904 | |
| 5. | pondite |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | fishingregg 03/05/2018 G1 Therapeutics Announces Positive Trilaciclib Phase 2a Topline Data Showing Robust Myelopreservation Benefits in Patients with Small Cell Lung Cancer |
| 2. | firefoxco 03/09/2018 G1 Therapeutics Announces Pricing of Offering of Common Stock |
| 3. | fishingregg 06/18/2018 Files for $125 mln mixed securities shelf offering |
| 4. | ykha5244 04/16/2018 G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer |
| 5. | fishingregg 03/05/2018 G1 Therapeutics Announces Proposed Offering of Common Stock |
| 6. | ykha5244 02/21/2018 Misses |
| 7. | ykha5244 05/18/2018 Needham & Co. raises PT to $60 |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
G1 Therapeutics, Inc.
- GTHX
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.